Click for best price
PET Radiopharmaceuticals Market Size, Share 2022
Market Analysis and Insights: Global PET Radiopharmaceuticals Market
The global PET Radiopharmaceuticals market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PET Radiopharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PET Radiopharmaceuticals market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PET Radiopharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PET Radiopharmaceuticals market.
Global PET Radiopharmaceuticals Scope and Market Size
PET Radiopharmaceuticals market is segmented by Type and by Application. Players, stakeholders, and other participants in the global PET Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
F-18
Ru-82
Others
Segment by Application
Oncology
Cardiology
Neurology
Others
By Company
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes PET Radiopharmaceuticals product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of PET Radiopharmaceuticals, with price, sales, revenue, and global market share of PET Radiopharmaceuticals from 2019 to 2022.
Chapter 3, the PET Radiopharmaceuticals competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PET Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the PET Radiopharmaceuticals market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PET Radiopharmaceuticals.
Chapter 13, 14, and 15, to describe PET Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 PET Radiopharmaceuticals Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global PET Radiopharmaceuticals Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 PET Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 F-18
1.2.3 Ru-82
1.2.4 Others
1.3 Market by Application
1.3.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global PET Radiopharmaceuticals Sales Estimates and Forecasts 2017-2028
2.2 Global PET Radiopharmaceuticals Revenue Estimates and Forecasts 2017-2028
2.3 Global PET Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global PET Radiopharmaceuticals Sales by Region
2.4.1 Global PET Radiopharmaceuticals Sales by Region (2017-2022)
2.4.2 Global Sales PET Radiopharmaceuticals by Region (2023-2028)
2.5 Global PET Radiopharmaceuticals Revenue by Region
2.5.1 Global PET Radiopharmaceuticals Revenue by Region (2017-2022)
2.5.2 Global PET Radiopharmaceuticals Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global PET Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global Top PET Radiopharmaceuticals Manufacturers by Sales (2017-2022)
3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PET Radiopharmaceuticals in 2021
3.2 Global PET Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Global PET Radiopharmaceuticals Revenue by Manufacturers (2017-2022)
3.2.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by PET Radiopharmaceuticals Revenue in 2021
3.3 Global PET Radiopharmaceuticals Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global PET Radiopharmaceuticals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global PET Radiopharmaceuticals Sales by Type
4.1.1 Global PET Radiopharmaceuticals Historical Sales by Type (2017-2022)
4.1.2 Global PET Radiopharmaceuticals Forecasted Sales by Type (2023-2028)
4.1.3 Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2028)
4.2 Global PET Radiopharmaceuticals Revenue by Type
4.2.1 Global PET Radiopharmaceuticals Historical Revenue by Type (2017-2022)
4.2.2 Global PET Radiopharmaceuticals Forecasted Revenue by Type (2023-2028)
4.2.3 Global PET Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
4.3 Global PET Radiopharmaceuticals Price by Type
4.3.1 Global PET Radiopharmaceuticals Price by Type (2017-2022)
4.3.2 Global PET Radiopharmaceuticals Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global PET Radiopharmaceuticals Sales by Application
5.1.1 Global PET Radiopharmaceuticals Historical Sales by Application (2017-2022)
5.1.2 Global PET Radiopharmaceuticals Forecasted Sales by Application (2023-2028)
5.1.3 Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2028)
5.2 Global PET Radiopharmaceuticals Revenue by Application
5.2.1 Global PET Radiopharmaceuticals Historical Revenue by Application (2017-2022)
5.2.2 Global PET Radiopharmaceuticals Forecasted Revenue by Application (2023-2028)
5.2.3 Global PET Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
5.3 Global PET Radiopharmaceuticals Price by Application
5.3.1 Global PET Radiopharmaceuticals Price by Application (2017-2022)
5.3.2 Global PET Radiopharmaceuticals Price Forecast by Application (2023-2028)
6 North America
6.1 North America PET Radiopharmaceuticals Market Size by Type
6.1.1 North America PET Radiopharmaceuticals Sales by Type (2017-2028)
6.1.2 North America PET Radiopharmaceuticals Revenue by Type (2017-2028)
6.2 North America PET Radiopharmaceuticals Market Size by Application
6.2.1 North America PET Radiopharmaceuticals Sales by Application (2017-2028)
6.2.2 North America PET Radiopharmaceuticals Revenue by Application (2017-2028)
6.3 North America PET Radiopharmaceuticals Market Size by Country
6.3.1 North America PET Radiopharmaceuticals Sales by Country (2017-2028)
6.3.2 North America PET Radiopharmaceuticals Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe PET Radiopharmaceuticals Market Size by Type
7.1.1 Europe PET Radiopharmaceuticals Sales by Type (2017-2028)
7.1.2 Europe PET Radiopharmaceuticals Revenue by Type (2017-2028)
7.2 Europe PET Radiopharmaceuticals Market Size by Application
7.2.1 Europe PET Radiopharmaceuticals Sales by Application (2017-2028)
7.2.2 Europe PET Radiopharmaceuticals Revenue by Application (2017-2028)
7.3 Europe PET Radiopharmaceuticals Market Size by Country
7.3.1 Europe PET Radiopharmaceuticals Sales by Country (2017-2028)
7.3.2 Europe PET Radiopharmaceuticals Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific PET Radiopharmaceuticals Market Size by Type
8.1.1 Asia Pacific PET Radiopharmaceuticals Sales by Type (2017-2028)
8.1.2 Asia Pacific PET Radiopharmaceuticals Revenue by Type (2017-2028)
8.2 Asia Pacific PET Radiopharmaceuticals Market Size by Application
8.2.1 Asia Pacific PET Radiopharmaceuticals Sales by Application (2017-2028)
8.2.2 Asia Pacific PET Radiopharmaceuticals Revenue by Application (2017-2028)
8.3 Asia Pacific PET Radiopharmaceuticals Market Size by Region
8.3.1 Asia Pacific PET Radiopharmaceuticals Sales by Region (2017-2028)
8.3.2 Asia Pacific PET Radiopharmaceuticals Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America PET Radiopharmaceuticals Market Size by Type
9.1.1 Latin America PET Radiopharmaceuticals Sales by Type (2017-2028)
9.1.2 Latin America PET Radiopharmaceuticals Revenue by Type (2017-2028)
9.2 Latin America PET Radiopharmaceuticals Market Size by Application
9.2.1 Latin America PET Radiopharmaceuticals Sales by Application (2017-2028)
9.2.2 Latin America PET Radiopharmaceuticals Revenue by Application (2017-2028)
9.3 Latin America PET Radiopharmaceuticals Market Size by Country
9.3.1 Latin America PET Radiopharmaceuticals Sales by Country (2017-2028)
9.3.2 Latin America PET Radiopharmaceuticals Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa PET Radiopharmaceuticals Market Size by Type
10.1.1 Middle East and Africa PET Radiopharmaceuticals Sales by Type (2017-2028)
10.1.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Type (2017-2028)
10.2 Middle East and Africa PET Radiopharmaceuticals Market Size by Application
10.2.1 Middle East and Africa PET Radiopharmaceuticals Sales by Application (2017-2028)
10.2.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2017-2028)
10.3 Middle East and Africa PET Radiopharmaceuticals Market Size by Country
10.3.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country (2017-2028)
10.3.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Cardinal Health Inc. (U.S.)
11.1.1 Cardinal Health Inc. (U.S.) Corporation Information
11.1.2 Cardinal Health Inc. (U.S.) Overview
11.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cardinal Health Inc. (U.S.) Recent Developments
11.2 Mallinckrodt plc (Ireland)
11.2.1 Mallinckrodt plc (Ireland) Corporation Information
11.2.2 Mallinckrodt plc (Ireland) Overview
11.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mallinckrodt plc (Ireland) Recent Developments
11.3 GE Healthcare (U.K.)
11.3.1 GE Healthcare (U.K.) Corporation Information
11.3.2 GE Healthcare (U.K.) Overview
11.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GE Healthcare (U.K.) Recent Developments
11.4 Lantheus Medical Imaging, Inc. (U.S.)
11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
11.4.2 Lantheus Medical Imaging, Inc. (U.S.) Overview
11.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
11.5 Bayer AG (Germany)
11.5.1 Bayer AG (Germany) Corporation Information
11.5.2 Bayer AG (Germany) Overview
11.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer AG (Germany) Recent Developments
11.6 Bracco Imaging S.p.A (Italy)
11.6.1 Bracco Imaging S.p.A (Italy) Corporation Information
11.6.2 Bracco Imaging S.p.A (Italy) Overview
11.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bracco Imaging S.p.A (Italy) Recent Developments
11.7 Eczacibasi-Monrol Nuclear Products (Turkey)
11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
11.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Overview
11.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
11.8 Nordion, Inc. (Canada)
11.8.1 Nordion, Inc. (Canada) Corporation Information
11.8.2 Nordion, Inc. (Canada) Overview
11.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nordion, Inc. (Canada) Recent Developments
11.9 Advanced Accelerator Applications S.A. (France)
11.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information
11.9.2 Advanced Accelerator Applications S.A. (France) Overview
11.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Advanced Accelerator Applications S.A. (France) Recent Developments
11.10 IBA Molecular Imaging (Belgium)
11.10.1 IBA Molecular Imaging (Belgium) Corporation Information
11.10.2 IBA Molecular Imaging (Belgium) Overview
11.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 IBA Molecular Imaging (Belgium) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 PET Radiopharmaceuticals Industry Chain Analysis
12.2 PET Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 PET Radiopharmaceuticals Production Mode & Process
12.4 PET Radiopharmaceuticals Sales and Marketing
12.4.1 PET Radiopharmaceuticals Sales Channels
12.4.2 PET Radiopharmaceuticals Distributors
12.5 PET Radiopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 PET Radiopharmaceuticals Industry Trends
13.2 PET Radiopharmaceuticals Market Drivers
13.3 PET Radiopharmaceuticals Market Challenges
13.4 PET Radiopharmaceuticals Market Restraints
14 Key Findings in The Global PET Radiopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global PET Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of F-18
Table 3. Major Manufacturers of Ru-82
Table 4. Major Manufacturers of Others
Table 5. Global PET Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global PET Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global PET Radiopharmaceuticals Sales by Region (2017-2022) & (K Pcs)
Table 8. Global PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Table 9. Global PET Radiopharmaceuticals Sales by Region (2023-2028) & (K Pcs)
Table 10. Global PET Radiopharmaceuticals Sales Market Share by Region (2023-2028)
Table 11. Global PET Radiopharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global PET Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
Table 13. Global PET Radiopharmaceuticals Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global PET Radiopharmaceuticals Revenue Market Share by Region (2023-2028)
Table 15. Global PET Radiopharmaceuticals Sales by Manufacturers (2017-2022) & (K Pcs)
Table 16. Global PET Radiopharmaceuticals Sales Share by Manufacturers (2017-2022)
Table 17. Global PET Radiopharmaceuticals Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2017-2022)
Table 19. PET Radiopharmaceuticals Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 20. Global PET Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2021)
Table 22. PET Radiopharmaceuticals Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers PET Radiopharmaceuticals Product Offered
Table 24. Date of Manufacturers Enter into PET Radiopharmaceuticals Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
Table 27. Global PET Radiopharmaceuticals Sales by Type (2023-2028) & (K Pcs)
Table 28. Global PET Radiopharmaceuticals Sales Share by Type (2017-2022)
Table 29. Global PET Radiopharmaceuticals Sales Share by Type (2023-2028)
Table 30. Global PET Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global PET Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global PET Radiopharmaceuticals Revenue Share by Type (2017-2022)
Table 33. Global PET Radiopharmaceuticals Revenue Share by Type (2023-2028)
Table 34. PET Radiopharmaceuticals Price by Type (2017-2022) & (USD/Pcs)
Table 35. Global PET Radiopharmaceuticals Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 36. Global PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
Table 37. Global PET Radiopharmaceuticals Sales by Application (2023-2028) & (K Pcs)
Table 38. Global PET Radiopharmaceuticals Sales Share by Application (2017-2022)
Table 39. Global PET Radiopharmaceuticals Sales Share by Application (2023-2028)
Table 40. Global PET Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global PET Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global PET Radiopharmaceuticals Revenue Share by Application (2017-2022)
Table 43. Global PET Radiopharmaceuticals Revenue Share by Application (2023-2028)
Table 44. PET Radiopharmaceuticals Price by Application (2017-2022) & (USD/Pcs)
Table 45. Global PET Radiopharmaceuticals Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 46. North America PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
Table 47. North America PET Radiopharmaceuticals Sales by Type (2023-2028) & (K Pcs)
Table 48. North America PET Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America PET Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
Table 51. North America PET Radiopharmaceuticals Sales by Application (2023-2028) & (K Pcs)
Table 52. North America PET Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America PET Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
Table 55. North America PET Radiopharmaceuticals Sales by Country (2023-2028) & (K Pcs)
Table 56. North America PET Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America PET Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe PET Radiopharmaceuticals Sales by Type (2023-2028) & (K Pcs)
Table 60. Europe PET Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe PET Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
Table 63. Europe PET Radiopharmaceuticals Sales by Application (2023-2028) & (K Pcs)
Table 64. Europe PET Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe PET Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
Table 67. Europe PET Radiopharmaceuticals Sales by Country (2023-2028) & (K Pcs)
Table 68. Europe PET Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe PET Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
Table 71. Asia Pacific PET Radiopharmaceuticals Sales by Type (2023-2028) & (K Pcs)
Table 72. Asia Pacific PET Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific PET Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
Table 75. Asia Pacific PET Radiopharmaceuticals Sales by Application (2023-2028) & (K Pcs)
Table 76. Asia Pacific PET Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific PET Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific PET Radiopharmaceuticals Sales by Region (2017-2022) & (K Pcs)
Table 79. Asia Pacific PET Radiopharmaceuticals Sales by Region (2023-2028) & (K Pcs)
Table 80. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
Table 83. Latin America PET Radiopharmaceuticals Sales by Type (2023-2028) & (K Pcs)
Table 84. Latin America PET Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America PET Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
Table 87. Latin America PET Radiopharmaceuticals Sales by Application (2023-2028) & (K Pcs)
Table 88. Latin America PET Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America PET Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
Table 91. Latin America PET Radiopharmaceuticals Sales by Country (2023-2028) & (K Pcs)
Table 92. Latin America PET Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America PET Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
Table 95. Middle East and Africa PET Radiopharmaceuticals Sales by Type (2023-2028) & (K Pcs)
Table 96. Middle East and Africa PET Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa PET Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
Table 99. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2023-2028) & (K Pcs)
Table 100. Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
Table 103. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2023-2028) & (K Pcs)
Table 104. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 106. Cardinal Health Inc. (U.S.) Corporation Information
Table 107. Cardinal Health Inc. (U.S.) Description and Major Businesses
Table 108. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 109. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Cardinal Health Inc. (U.S.) Recent Developments
Table 111. Mallinckrodt plc (Ireland) Corporation Information
Table 112. Mallinckrodt plc (Ireland) Description and Major Businesses
Table 113. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 114. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Mallinckrodt plc (Ireland) Recent Developments
Table 116. GE Healthcare (U.K.) Corporation Information
Table 117. GE Healthcare (U.K.) Description and Major Businesses
Table 118. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 119. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. GE Healthcare (U.K.) Recent Developments
Table 121. Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
Table 122. Lantheus Medical Imaging, Inc. (U.S.) Description and Major Businesses
Table 123. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 124. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
Table 126. Bayer AG (Germany) Corporation Information
Table 127. Bayer AG (Germany) Description and Major Businesses
Table 128. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 129. Bayer AG (Germany) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Bayer AG (Germany) Recent Developments
Table 131. Bracco Imaging S.p.A (Italy) Corporation Information
Table 132. Bracco Imaging S.p.A (Italy) Description and Major Businesses
Table 133. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 134. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Bracco Imaging S.p.A (Italy) Recent Developments
Table 136. Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
Table 137. Eczacibasi-Monrol Nuclear Products (Turkey) Description and Major Businesses
Table 138. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 139. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
Table 141. Nordion, Inc. (Canada) Corporation Information
Table 142. Nordion, Inc. (Canada) Description and Major Businesses
Table 143. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 144. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Nordion, Inc. (Canada) Recent Developments
Table 146. Advanced Accelerator Applications S.A. (France) Corporation Information
Table 147. Advanced Accelerator Applications S.A. (France) Description and Major Businesses
Table 148. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 149. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Advanced Accelerator Applications S.A. (France) Recent Developments
Table 151. IBA Molecular Imaging (Belgium) Corporation Information
Table 152. IBA Molecular Imaging (Belgium) Description and Major Businesses
Table 153. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 154. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. IBA Molecular Imaging (Belgium) Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. PET Radiopharmaceuticals Distributors List
Table 159. PET Radiopharmaceuticals Customers List
Table 160. PET Radiopharmaceuticals Market Trends
Table 161. PET Radiopharmaceuticals Market Drivers
Table 162. PET Radiopharmaceuticals Market Challenges
Table 163. PET Radiopharmaceuticals Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. PET Radiopharmaceuticals Product Picture
Figure 3. Global PET Radiopharmaceuticals Market Share by Type in 2021 & 2028
Figure 3. F-18 Product Picture
Figure 4. Ru-82 Product Picture
Figure 5. Others Product Picture
Figure 6. Global PET Radiopharmaceuticals Market Share by Application in 2021 & 2028
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Neurology
Figure 10. Others
Figure 11. PET Radiopharmaceuticals Report Years Considered
Figure 12. Global PET Radiopharmaceuticals Sales 2017-2028 (K Pcs)
Figure 13. Global PET Radiopharmaceuticals Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global PET Radiopharmaceuticals Revenue 2017-2028 (US$ Million)
Figure 15. Global PET Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Figure 17. Global PET Radiopharmaceuticals Sales Market Share by Region (2023-2028)
Figure 18. North America PET Radiopharmaceuticals Sales YoY (2017-2028) & (K Pcs)
Figure 19. North America PET Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe PET Radiopharmaceuticals Sales YoY (2017-2028) & (K Pcs)
Figure 21. Europe PET Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific PET Radiopharmaceuticals Sales YoY (2017-2028) & (K Pcs)
Figure 23. Asia-Pacific PET Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America PET Radiopharmaceuticals Sales YoY (2017-2028) & (K Pcs)
Figure 25. Latin America PET Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa PET Radiopharmaceuticals Sales YoY (2017-2028) & (K Pcs)
Figure 27. Middle East & Africa PET Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The PET Radiopharmaceuticals Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of PET Radiopharmaceuticals in the World: Market Share by PET Radiopharmaceuticals Revenue in 2021
Figure 30. Global PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 32. Global PET Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 33. Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 34. Global PET Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 35. North America PET Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 36. North America PET Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 37. North America PET Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 38. North America PET Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 39. North America PET Radiopharmaceuticals Sales Share by Country (2017-2028)
Figure 40. North America PET Radiopharmaceuticals Revenue Share by Country (2017-2028)
Figure 41. U.S. PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 42. Canada PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 43. Europe PET Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 44. Europe PET Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 45. Europe PET Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 46. Europe PET Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 47. Europe PET Radiopharmaceuticals Sales Share by Country (2017-2028)
Figure 48. Europe PET Radiopharmaceuticals Revenue Share by Country (2017-2028)
Figure 49. Germany PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 50. France PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 52. Italy PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 53. Russia PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific PET Radiopharmaceuticals Sales Share by Region (2017-2028)
Figure 59. Asia Pacific PET Radiopharmaceuticals Revenue Share by Region (2017-2028)
Figure 60. China PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 61. Japan PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 63. India PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 64. Australia PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America PET Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 71. Latin America PET Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 72. Latin America PET Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 73. Latin America PET Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 74. Latin America PET Radiopharmaceuticals Sales Share by Country (2017-2028)
Figure 75. Latin America PET Radiopharmaceuticals Revenue Share by Country (2017-2028)
Figure 76. Mexico PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa PET Radiopharmaceuticals Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa PET Radiopharmaceuticals Revenue Share by Country (2017-2028)
Figure 85. Turkey PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 87. UAE PET Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 88. PET Radiopharmaceuticals Value Chain
Figure 89. PET Radiopharmaceuticals Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
